Orbis Medicines
An Associate Scientist or Scientist in the Screening Biology department will develop and optimize biochemical and cellular assays for high-throughput screening at Orbis Medicines. This role involves designing scalable biological assays, ensuring data quality, executing screening campaigns, and collaborating with AI, chemistry, and data science teams to advance drug discovery. The position offers the opportunity to work with automation platforms and contribute to the company's innovative nGen chemistry approach.
Orbis Medicines is a biopharmaceutical company focused on oral macrocycle drug discovery, developing next-generation small molecule drugs called nCycles that can target diseases traditionally treated with injectable biologic therapies. The company's proprietary nGen platform uses high-throughput chemistry, DNA-encoded libraries, and AI-driven deep learning to systematically explore macrocycle chemical space and identify orally bioavailable drug candidates. Orbis Medicines aims to provide oral alternatives to blockbuster biologic drugs, enabling treatment of a broader patient population across multiple therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Orbis Medicines.
Orbis Medicines didn’t post a salary, so this is our estimate from similar listings.
Senior Research Scientist Platform Biology
Arvinas
Scientist I, In Vitro Pharmacology
Flagship Pioneering, Inc.
Cell-Based Assay Development Lead (Night Shift)
Wolf & Badger
Scientist I – In vitro Cancer Biology
Bristol Myers Squibb
Senior Scientist II, Invitro Bioassay, Molecular Screening and Characterization
AbbVie
Cell‑Based Assay Scientist
Wolf & Badger